Longitudinal data shows increasing or high addictive use of social media and mobile phones in adolescents significantly raises the risk of suicidal behaviors and ideation.
The FDA has approved Uzedy (risperidone) as monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I disorder in adults.
(HealthDay News) — Brief bouts of exercise spread throughout the day (“exercise snacks”) improve cardiorespiratory fitness in physically inactive adults, according to a review published online in the ...
(HealthDay News) — Among U.S. military personnel and veterans reporting recent suicidal ideation and/or suicidal behaviors, brief cognitive behavioral therapy (BCBT) reduces suicide attempts, ...
Evidence seen, however, for harmful effects from serious adverse events and several nonserious adverse events.
(HealthDay News) — The risk for amyotrophic lateral sclerosis (ALS) is higher in the 2 years after a traumatic brain injury (TBI), according to a study published online Oct. 2 in JAMA Network Open.
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for CTx-1301 for the treatment of attention deficit/hyperactivity disorder (ADHD) in children and adults.
Resilience training (RT), a brief mindfulness-based intervention, reduced early psychopathology, emotion reactivity, and altered hippocampal-prefrontal brain connectivity in at-risk young adults.
This 3-part series looks at the evidence for the treatment of SUDs reviews & the use of GLP-1 receptor agonists and alcohol use disorder.
The FDA has granted Fast Track designation to CS-1103 for the treatment of acute methamphetamine intoxication.
After 30 days with ambient AI scribe, proportion of participants experiencing burnout decreased from 51.9 to 38.8 percent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback